Search
for
Sort by
Research 31–60 of 46
- Hair follicle–derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma
- Skin CD4+ memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- Long‐term outcome after hand and forearm transplantation – a retrospective study
- Alopecia areata – Current understanding and management
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Alopecia areata – Aktuelles Verständnis und Management
- Redefining the Skin Barrier: A Microbiome‐Integrated Multilayered Defense Model
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- ZALCITABINE
- Stem-cell therapy in dermatology – Challenges and opportunities
- Case of alemtuzumab-related alopecia areata management in MS
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- 3162 Alopecia universalis after alemtuzumab in multiple sclerosis - a nine year follow up and review of literature
- Alemtuzumab-Induced Secondary Autoimmune Skin Disorders as Side Effects of Multiple Sclerosis Therapy: Problem That Can Be Influenced or Fate? A Narrative Overview of The Literature A Neuroprotective Role of Vitamin D?
- Mycosis Fungoides in Elderly Adults—A Diagnostic Challenge
- Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis
- Index
- Mechanisms regulating skin immunity and inflammation
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Current management strategies for cutaneous T-cell lymphoma
- Teriflunomide in multiple sclerosis: an update